Publication & Citation Trends
Most Cited Works
Publications
162 total
TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1.
Cited by 24
Semantic Scholar
Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation OA
Cited by 86
Semantic Scholar
Corrigendum to "Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation" [Lung Cancer 112 (October) (2017) 81-89]. OA
Cited by 0
Semantic Scholar
Antagonizing SET Augments the Effects of Radiation Therapy in Hepatocellular Carcinoma through Reactivation of PP2A-Mediated Akt Downregulation OA
Cited by 11
Semantic Scholar
Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
Cited by 69
Semantic Scholar
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma
Cited by 7
Semantic Scholar
Corrigendum to "Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity" [Eur. J. Med. Chem. 55 (2012) 220-227].
Cited by 2
Semantic Scholar
Abstract 4372: SET/PP2A/SHP-1/Lyn oncogenic signaling contributes to tumor aggressiveness in diffuse large B cell lymphoma
Cited by 0
Semantic Scholar
Research Topics
Protein Tyrosine Phosphatases
(46)
Cancer-related Molecular Pathways
(34)
Cytokine Signaling Pathways and Interactions
(34)
Cancer Mechanisms and Therapy
(27)
PI3K/AKT/mTOR signaling in cancer
(26)
Frequent Co-Authors
Affiliations
Fu Jen Catholic University
National Yang Ming Chiao Tung University
Chulalongkorn University
National Taiwan University
National Central University